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Erratum
Relationship between expression of topoisomerase II isoforms
and intrinsic sensitivity to topoisomerase II inhibitors in breast
cancer cell lines
S Houlbrook, CM Addison, SL Davies, J Carmichael,
IJ Stratford, AL Harris and ID Hickson
British Journal of Cancer, 1995; 72: 1454-1461
Since the publication of the above paper, the authors have
identified an error on the legend for Figure 5. The correct
legend should read:
Figure 5 Ribonuclease protection analysis of topoisomerase Ila
and topoisomerase II,l mRNA levels in human breast cancer cell
lines. An autoradiogram of an acrylamide gel showing the
mobility of RNA species protected from RNase digestion.
Lanes: M, molecular weight standards, as indicated in base pairs
on the left; 1, MDA 231; 2, MDA 468; 3, SkBr3; 4, T47D; 5,
ZR75; 6, MCF-7. The positions of the topoisomerase IIa
protected fragment and the two alternately spliced topoisomerase
II,B transcripts (/31 and ,B2) are indicated on the right. The
GAPDH-specific protection fragment is also indicated on the
right. Densitometric scanning of autoradiograms was conducted
when each signal was within the linear range for X-ray film.